GlassScriptPhysician profile
Christopher E Danielski
NPI 1649671223
$762.23
in general payments reported to CMS, 2019-2025
12 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.00 · 2023: $226 · 2024: $165 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $194.36 | 2023-2025 | Euflexxa |
| Vertos Medical, INC. | $131.94 | 2023 | Mild Device Kit |
| Abbvie INC. | $84.45 | 2023-2025 | |
| Averitas Pharma INC. | $67.55 | 2025 | Qutenza |
| Bioventus LLC | $63.56 | 2023-2025 | Xcell, Durolane |
| Vertex Pharmaceuticals Incorporated | $52.45 | 2025 | |
| Tactile Systems Technology INC | $43.91 | 2025 | Nimbl, Flexitouch Plus |
| Djo, LLC | $41.90 | 2024 | Cmf |
| Recordati_rare_diseases_inc. | $25.99 | 2025 | Isturisa |
| Xeris Pharmaceuticals, INC. | $23.03 | 2024 | Recorlev |
| Tonix Medicines, INC. | $19.09 | 2025 | Tonmya |
| Relievant Medsystems, INC. | $14.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Danielski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.